Jasper Therapeutics Files 8-K on Financials
Ticker: JSPRW · Form: 8-K · Filed: Feb 27, 2025 · CIK: 1788028
| Field | Detail |
|---|---|
| Company | Jasper Therapeutics, Inc. (JSPRW) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, sec-filing
Related Tickers: JSPR
TL;DR
Jasper Therapeutics dropped an 8-K detailing financials - check it for the latest on their operations.
AI Summary
Jasper Therapeutics, Inc. filed an 8-K on February 27, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing details the company's status as a biological products company incorporated in Delaware.
Why It Matters
This filing provides investors with crucial updates on Jasper Therapeutics' financial health and operational performance, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Jasper Therapeutics, Inc. (company) — Registrant
- February 27, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Amplitude Healthcare Acquisition Corp (company) — Former Company Name
FAQ
What is the primary purpose of this 8-K filing for Jasper Therapeutics, Inc.?
The primary purpose of this 8-K filing is to report on Jasper Therapeutics, Inc.'s results of operations and financial condition, as well as to provide financial statements and exhibits.
On what date was this 8-K report filed?
This 8-K report was filed on February 27, 2025.
In which state was Jasper Therapeutics, Inc. incorporated?
Jasper Therapeutics, Inc. was incorporated in Delaware.
What was Jasper Therapeutics, Inc.'s former company name?
Jasper Therapeutics, Inc.'s former company name was Amplitude Healthcare Acquisition Corp.
What is Jasper Therapeutics, Inc.'s Standard Industrial Classification (SIC) code and industry?
Jasper Therapeutics, Inc.'s SIC code is 2836, and its industry is Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 regarding Jasper Therapeutics, Inc. (JSPRW).